These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


2022 related items for PubMed ID: 26546334

  • 1. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
    Kim HJ, Cho A, Yun M, Kim YT, Kang WJ.
    Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
    [Abstract] [Full Text] [Related]

  • 2. High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging.
    Picchio M, Mangili G, Samanes Gajate AM, De Marzi P, Spinapolice EG, Mapelli P, Giovacchini G, Sigismondi C, Viganò R, Sironi S, Messa C.
    Nucl Med Commun; 2010 Jun; 31(6):506-12. PubMed ID: 20168262
    [Abstract] [Full Text] [Related]

  • 3. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.
    Crivellaro C, Signorelli M, Guerra L, De Ponti E, Pirovano C, Fruscio R, Elisei F, Montanelli L, Buda A, Messa C.
    Gynecol Oncol; 2013 Aug; 130(2):306-11. PubMed ID: 23707673
    [Abstract] [Full Text] [Related]

  • 4. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA, Reitan BC, Biermann M, Trovik J, Bjørge L, Magnussen IJ, Salvesen ØO, Salvesen HB, Haldorsen IS.
    J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer.
    Park JY, Kim EN, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.
    Gynecol Oncol; 2008 Mar; 108(3):486-92. PubMed ID: 18201753
    [Abstract] [Full Text] [Related]

  • 6. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH, Bouchelouche K, Høilund-Carlsen PF, Petersen H, Gerke O, Steffansen SI, Marcussen N, Svolgaard N, Vach W, Geertsen U, Walter S.
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [Abstract] [Full Text] [Related]

  • 7. Comparison of MRI and 18F-FDG PET/CT in the preoperative evaluation of uterine carcinosarcoma.
    Lee HJ, Park JY, Lee JJ, Kim MH, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.
    Gynecol Oncol; 2016 Mar; 140(3):409-14. PubMed ID: 26777990
    [Abstract] [Full Text] [Related]

  • 8. Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases.
    Stecco A, Buemi F, Cassarà A, Matheoud R, Sacchetti GM, Arnulfo A, Brambilla M, Carriero A.
    Radiol Med; 2016 Jul; 121(7):537-45. PubMed ID: 27033474
    [Abstract] [Full Text] [Related]

  • 9. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K.
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
    Ishiguchi H, Ito S, Kato K, Sakurai Y, Kawai H, Fujita N, Abe S, Narita A, Nishio N, Muramatsu H, Takahashi Y, Naganawa S.
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [Abstract] [Full Text] [Related]

  • 11. Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: comparison with MRI findings.
    Lv K, Guo HM, Lu YJ, Wu ZX, Zhang K, Han JK.
    Nucl Med Commun; 2014 Dec; 35(12):1204-11. PubMed ID: 25222911
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
    Manabe O, Hattori N, Hirata K, Itoh K, Hosokawa M, Takahashi H, Oyama-Manabe N, Tamaki N.
    J Nucl Med; 2013 May; 54(5):670-6. PubMed ID: 23516310
    [Abstract] [Full Text] [Related]

  • 13. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
    Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, Werbrouck P.
    Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
    [Abstract] [Full Text] [Related]

  • 14. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
    Konuralp Atakul B, Taşkın S, Soydal Ç, Sükür YE, Kahraman A, Koyuncu K, İbiş E, Ortac F.
    Gynecol Obstet Invest; 2017 Apr; 82(4):340-348. PubMed ID: 27771729
    [Abstract] [Full Text] [Related]

  • 15. 2-fluoro-2-deoxy-D-glucose positron emission tomography versus conventional imaging for the diagnosis of breast cancer and lymph node metastases.
    Shao M, Zi J, Wen G.
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S661-S666. PubMed ID: 30249884
    [Abstract] [Full Text] [Related]

  • 16. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
    Park JY, Lee JJ, Choi HJ, Song IH, Sung CO, Kim HO, Chae SY, Kim YT, Nam JH.
    Ann Surg Oncol; 2017 Aug; 24(8):2303-2310. PubMed ID: 28550488
    [Abstract] [Full Text] [Related]

  • 17. FDG PET/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer.
    Sudo S, Hattori N, Manabe O, Kato F, Mimura R, Magota K, Sugimori H, Hirata K, Sakuragi N, Tamaki N.
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):676-84. PubMed ID: 25504022
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
    Herbrik M, Treffert J, Geiger B, Riegger C, Hartung V, Rosenbaum-Krumme SJ, Forsting M, Antoch G, Heusner TA.
    J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
    [Abstract] [Full Text] [Related]

  • 19. FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy.
    Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim CS.
    Ann Surg Oncol; 2015 Sep; 22(9):3150-6. PubMed ID: 25634779
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
    Hahn S, Hecktor J, Grabellus F, Hartung V, Pöppel T, Kimmig R, Forsting M, Antoch G, Heusner TA.
    Acta Radiol; 2012 Jun 01; 53(5):518-23. PubMed ID: 22547387
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 102.